TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Evaxion Biotech A/S
Closing information (x1000 SEK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
755
|
0
|
0 |
| Earnings before taxes |
-235,105
|
-254,091
|
-220,613 |
| Total assets |
137,663
|
225,126
|
361,712 |
| Current assets |
83,515
|
165,644
|
306,145 |
| Current liabilities |
79,358
|
34,575
|
38,314 |
| Equity capital |
-47,483
|
86,628
|
292,682 |
| - share capital |
56,423
|
36,124
|
31,912 |
| Employees (average) |
35
|
35
|
35 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
-34.5%
|
38.5%
|
80.9% |
| Turnover per employee |
22
|
0
|
0 |
| Profit as a percentage of turnover | -31139.7% | ||
| Return on assets (ROA) | |||
| Current ratio |
105.2%
|
479.1%
|
799.0% |
| Return on equity (ROE) |
495.1%
|
-293.3%
|
-75.4% |
| Change turnover |
755
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.